1999
DOI: 10.1021/bc980086+
|View full text |Cite
|
Sign up to set email alerts
|

Polymeric Gadolinium Chelate Magnetic Resonance Imaging Contrast Agents:  Design, Synthesis, and Properties

Abstract: We have synthesized and evaluated five series of polymeric gadolinium chelates which are of interest as potential MRI blood pool contrast agents. The polymers were designed so that important physical properties including molecular weight, relaxivity, metal content, viscosity, and chelate stability could be varied. We have shown that, by selecting polymers of the appropriate MW, extended blood pool retention can be achieved. In addition, relaxivity can be manipulated by changing the polymer rigidity, metal cont… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
55
0
1

Year Published

2005
2005
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 67 publications
(57 citation statements)
references
References 29 publications
1
55
0
1
Order By: Relevance
“…Macromolecular Gd(III) complexes have a potential for improved blood pool pharmacokinetics and MR contrast enhancement when compared to low-molecular-weight Gd(III) complexes (4)(5)(6). A number of macromolecular Gd(III) complexes have been prepared as blood pool MRI contrast agents (7)(8)(9)(10)(11)(12)(13). Macromolecular Gd(III) complexes significantly increase blood pool and tissue retention time of contrast agents, resulting in superior contrast enhancement in animal models.…”
Section: Introductionmentioning
confidence: 99%
“…Macromolecular Gd(III) complexes have a potential for improved blood pool pharmacokinetics and MR contrast enhancement when compared to low-molecular-weight Gd(III) complexes (4)(5)(6). A number of macromolecular Gd(III) complexes have been prepared as blood pool MRI contrast agents (7)(8)(9)(10)(11)(12)(13). Macromolecular Gd(III) complexes significantly increase blood pool and tissue retention time of contrast agents, resulting in superior contrast enhancement in animal models.…”
Section: Introductionmentioning
confidence: 99%
“…However, their clinical application is limited because of their transient tissue retention and unfavorable pharmacokinetics, which includes rapid extravasation from the cardiovasculature and undiscriminable distribution into the extracellular space (5,6). As a result, macromolecular Gd(III) chelates have been developed as blood pool MRI contrast agents to modify in vivo pharmacokinetics (5Y9).…”
Section: Introductionmentioning
confidence: 99%
“…The best results were obtained with a dOTA dendrimer that was the result of the incorporation of optimized features, that is, high rigidity, low viscosity, high number of Gd 3+ chelate, and high stability provided by the dOTA. These combined characteristics contributed to a long blood half-life and a high relaxivity [55]. …”
Section: Enhanced Relaxivity and Circulation Timementioning
confidence: 99%